Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir-treated HCV-infected patients: A real-world clinical experience-Reference-Cited by-同舟云学术

Prevalence of thyroid stimulating hormone dysfunction among sofosbuvir-treated HCV-infected patients: A real-world clinical experience

Published:2018-10-17 Issue:3 Volume:91 Page:514-517
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Wahid Braira¹,Waqar Muhammad²^ORCID,Rasool Nouman¹³,Wasim Muhammad⁴,Khalid Ifrah⁵,Idrees Muhammad⁶^ORCID

Affiliation:

1. Department of Life Sciences; School of Science, University of Management and Technology; Lahore Pakistan

2. Centre for Applied Molecular Biology, University of the Punjab; Lahore Pakistan

3. Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi; Karachi Pakistan

4. Department of Medicine; Khyber Teaching Hospital; Peshawar KPK Pakistan

5. Division of Molecular Virology; Centre of Excellence in Molecular Biology, University of the Punjab; Lahore Pakistan

6. Hazara University Mansehra; Pakistan

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.25319/fullpdf

Reference27 articles.

1. Development of global consensus sequence and analysis of highly conserved domains of the HCV NS5B prote in;Waheed;Hepat Mon,2012

2. Extrahepatic manifestations of chronic hepatitis C virus infection;Cacoub;Ther Adv Infect Dis,2016

3. Frequency of thyroid dysfunctions during interferon alpha treatment of single and combination therapy in hepatitis C virus-infected patients: a systematic review based analysis;Nair Kesavachandran;PLoS One,2013

4. Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective;Tran;Endocr Pract,2013

5. Peginterferon lambda-1a is associated with a low incidence of autoimmune thyroid disease in chronic hepatitis C;Fredlund;J Interferon Cytokine Res,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment response and adverse effects of direct acting antivirals among HCV patients carrying comorbid conditions;Future Virology;2024-03-03

2. Direct-acting antivirals used in HCV-related liver disease do not affect thyroid function and autoimmunity;Journal of Endocrinological Investigation;2022-09-01

3. COVID-19 and the Thyroid Function in Patients with HCV - Associated Hepatocellular Carcinoma;Acta Endocrinologica (Bucharest);2022

4. A Prospective Observational Study of 42 Patients with COVID-19 infection and a History of Hepatitis C Virus Infection and Thyroid Disease with Follow-Up Thyroid Function and Autoantibody Testing;Medical Science Monitor;2021-12-21

5. Assessment of thyroid function in patients with chronic hepatitis C virus infection before and after treatment with oral direct-antiviral drugs;Al-Azhar Assiut Medical Journal;2021-01